Oxytocin 30 Units added to NS 500 mL — Class III drug recall D-0499-2019
Terminated recall by Advanced Pharma Inc., reported 2019-02-27, distributed nationwide. Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.
| Recall number | D-0499-2019 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Advanced Pharma Inc., Houston, TX, United States |
| Recall initiated | 2019-02-06 |
| Classified | 2019-02-15 |
| Reported by FDA | 2019-02-27 |
| Terminated | 2019-10-30 |
| Distributed | Nationwide (US) |
| Quantity | 1,460 bottles |
| Reason classes | labeling, potency |
| NDC | 42852-0706-50 |
| Lot numbers | 3177, 5698, 6618, 70650P, 7716 |
| Expiration dates | 2019-02-10, 2019-02-12, 2019-03-16 |
Product
Oxytocin 30 Units added to NS 500 mL (oxytocin and 0.9% Sodium Chloride) Injectable Solution, Approximately 503 mL Sterile single use bag, Rx only, Avella of Houston, 9265 Kirby Dr., Houston, TX 77054, NDC 42852-706-50.
Reason for recall
Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0499-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.